InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: EYEBUYSTOX post# 216758

Friday, 04/24/2015 2:06:48 PM

Friday, April 24, 2015 2:06:48 PM

Post# of 345747
EBS, even after all kinds of Greek food, wine and offered beverages of the House I am still sufficiently clearly thinking to say I do not agree.

If those drugs are SO SUCCESSFUL EVEN THEN we can all stand on our heads and make turns but they have :

- SMALL RESPONDER FOOTPRINTS compared to PPHM's bavituximab
- LOTS OF NASTY KILLING SIDE EFFECTS (see Lawsuits Yevoy)
- They will not beat Doce by 100% (Actually - mark my words - it is about 7 months - so less then 50%).

You can save this post to prove me wrong when you hear the results from BMY themselves and don't get in my hair if it is 7.9 or 6.5 months.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News